A Real-World Characterization of US Patients with "Moderate-to-Severe" Systemic Lupus Erythematosus.

被引：0
|
作者：
Strand, Vibeke
Johnson, Jennifer [1 ]
Vandeloo, Carl [2 ]
Galateanu, Catrinel [2 ]
Lobosco, Steve [1 ]
机构：
[1] Adelphi Real World Ltd, Macclesfield, Cheshire, England
[2] UCB Pharma, Brussels, Belgium
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1077
引用
收藏
页码：S475 / S475
页数：1
相关论文
共 50 条
  • [21] RECENT REAL-WORLD TRENDS IN MANAGEMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) BY US COMMUNITY RHEUMATOLOGISTS
    Radtchenko, J.
    Pallett, P.
    Stockton, C. M.
    Feinberg, B. A.
    [J]. VALUE IN HEALTH, 2018, 21 : S265 - S265
  • [22] Real-world data on the use of secukinumab as treatment for moderate-to-severe psoriasis in Chinese patients
    Huang, He
    Cai, Ming-Long
    Hong, Xiao-Jie
    Zheng, Li-Jun
    Hu, Zhu-Lin
    Yuan, Tao
    Li, Wei-Ran
    Sheng, Yu-Jun
    Zhang, Xue-Jun
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (05) : 554 - 560
  • [23] REAL-WORLD EFFECTIVENESS OF DUPILUMAB ON ORAL CORTICOSTEROID USE IN PATIENTS WITH MODERATE-TO-SEVERE ASTHMA
    Pawar, A.
    Blaiss, M.
    Modena, B.
    Khan, A.
    DePrado-Gomez, L.
    Pandit-Abid, N.
    Radwan, A.
    Jacob-Nara, J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S48 - S49
  • [24] Real-world data on the use of secukinumab as treatment for moderate-to-severe psoriasis in Chinese patients
    He Huang
    Ming-Long Cai
    Xiao-Jie Hong
    Li-Jun Zheng
    Zhu-Lin Hu
    Tao Yuan
    Wei-Ran Li
    Yu-Jun Sheng
    Xue-Jun Zhang
    [J]. European Journal of Dermatology, 2020, 30 : 554 - 560
  • [25] A real-world study of symptomatic eosinophilia in moderate-to-severe asthma patients on dupilumab therapy
    Fisch, Matthew
    Fajt, Merritt L.
    Wenzel, Sally E.
    Petrov, Andrej A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (08): : 2183 - 2186
  • [26] Real-world data on the efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis
    Papadavid, E.
    Rompoti, N.
    Theodoropoulos, K.
    Kokkalis, G.
    Rigopoulos, D.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (07) : 1173 - 1179
  • [27] Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting
    Ogut, Neslihan Demirel
    Yildirim, Sema Koc
    Erbagci, Ece
    Hapa, Fatma Asli
    [J]. JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (11) : 6215 - 6224
  • [28] Cancer screening in patients with systemic lupus erythematosus.
    Bernatsky, S
    Clarke, A
    Cooper, G
    Mill, C
    Ramsey-Goldman, R
    Pineau, CA
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S388 - S388
  • [29] Premature Delivery in Patients with Systemic Lupus Erythematosus.
    Arturi, Valeria
    Sansinanea, Pierina
    Alejandra Pera, Mariana
    Pablo Salas, Adrian
    Marcos, Josefina
    Carolina Costi, Ana
    Elizabeth Pena, Claudia
    Argentina Garcia, Mercedes
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1169 - S1169
  • [30] ENTEROCOCCUS GALLINARUM IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
    Vega Sevilla, L. F.
    Alvarez-Gonzalez, O. E.
    Riega-Torres, J. C.
    Rubio Torres, D. C.
    Skinner Taylor, C. M.
    Vera Cabrera, L.
    Cardenas-de la Garza, J. A.
    Aguilera Valenciano, M. A.
    Escalante, W.
    Guerra, H.
    Galarza-Delgado, D. A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1240 - 1241
12345